MedAdvisor has announced
closure of its public fund-raising for
their ASX listing with subscriptions
exceeding the maximum limit of
$5m.
Pharmacists were protected from
scale back through the MedAdvisor
Pharmacy Priority Offer, the
company said.
The offer drew strong support
from a wide range of investors, with
16% of investment coming from
pharmacies and pharmacy groups
nationwide.
Interested pharmacists who
missed out on the public offering
can invest in MedAdvisor when it
commences trading as MedAdvisor
(ASX:MDR) in Nov 2015.
MedAdvisor is the most
downloaded Australian (Apple and
Android) medication-related app.The above article was sent to subscribers in Pharmacy Daily's issue from 20 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.